Market Research Report

A quick peek into the report

Europe Next Generation Sequencing (NGS) Market

Analysis and Forecast, 2023-2033

 
Some Faq's

Frequently Asked Questions

Genomic sequencing and life science companies, as well as startups looking to enter the NGS market, should buy this report.

The Global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2023-2033.

NGS technology differs from traditional DNA sequencing by its high-throughput capabilities, allowing simultaneous processing of multiple DNA sequences. It offers advantages such as faster results, lower costs, and the ability to sequence large genomic regions, making it invaluable in genomics research, clinical diagnostics, and personalized medicine.

Emerging trends in the NGS market include single-cell sequencing, liquid biopsy applications, and increasing adoption in clinical settings. Future prospects involve continued technological advancements, improved data analysis tools, and expanded applications in fields like agriculture, microbiology, and oncology, promising further growth and innovation in the NGS field